YOLFTbeta
30

Hunan Er Kang Pharmaceutical

300267 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

2.83CNY-0.09 (-3.08%)

Price History

Full chart

Market Stats

Previous Close2.92
Open2.91
Day Range2.81 – 2.92
52-Week Range2.78 – 5.11
Volume29.91M
Market Cap6.72B
P/E (TTM)0.00
Forward P/E27.86
EPS-0.18
Dividend Yield0.00%
Beta0.47
50-Day Avg3.21
200-Day Avg3.68

About

Hunan Er-Kang Pharmaceutical Co., Ltd engages in the research and development, production, and sale of pharmaceutical excipients, APIs and finished drugs in China and internationally. The company offers various APIs, such as glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. It also provides finished drugs, including sulbenicillin sodium for injection and compound liquorice tablets. In addition, the company offers conventional pharmaceutical excipients, such as pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprising of hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate products. Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Qingrong Sun
  • Employees1.27K
  • HeadquartersLiuyang Economic Development Zone, Changsha, China, 410331, China
  • Websitehttps://www.hnerkang.com

Leadership

  • Mr. Qingrong SunGM & Non-Independent Director · b. 1986
  • Ms. Zhao XunCFO & Employee Representative Director · b. 1988
  • Ms. Xiangyang ShiDeputy GM & Non Independent Director · b. 1971
  • Mr. Jiang XiaoChief Engineer · b. 1986
  • Mr. Jishun GuDeputy GM & Board Secretary · b. 1966
  • Mr. Zhengchun ZhengDeputy General Manager · b. 1969
  • Mr. Licheng ZhangDeputy General Manager · b. 1979
  • Mr. Wang HuiDeputy General Manager · b. 1984
  • Yuhua KuangAccounting Supervisor

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue126.13M157.83M363.93M608.42M834.86M1.01B1.37B1.76B2.71B2.83B2.35B2.74B2.38B2.24B1.87B1.78B1.14B1.17B
Growth (%)-+25.13%+130.58%+67.18%+37.22%+21.08%+35.57%+28.14%+54.09%+4.51%-16.74%+16.56%-13.19%-6.17%-16.32%-4.67%-36.09%+2.29%
Cost of Revenue84.96M99.29M216.04M359.76M532.32M647.28M789.26M854.18M1.55B1.78B1.53B2.06B1.86B1.92B1.46B1.50B849.75M857.49M
Gross Profit41.17M58.54M147.89M248.65M302.54M363.55M581.10M901.82M1.16B1.05B821.06M686.16M523.46M319.44M410.79M281.73M289.86M308.27M
Gross Margin32.64%37.09%40.64%40.87%36.24%35.97%42.40%51.36%42.85%36.97%34.87%25.00%21.97%14.29%21.96%15.80%25.44%26.44%
Operating Expense27.68M32.75M69.93M113.08M124.14M139.29M250.64M255.53M334.45M456.41M472.39M504.77M305.86M1.14B397.01M488.46M660.47M292.56M
Operating Income13.49M25.79M77.97M135.58M178.40M224.26M330.46M646.29M824.93M589.20M348.66M181.39M217.59M-818.55M13.78M-206.73M-370.61M15.71M
Operating Margin10.70%16.34%21.42%22.28%21.37%22.19%24.11%36.80%30.49%20.84%14.81%6.61%9.13%-36.62%0.74%-11.59%-32.52%1.35%
EBITDA20.28M33.68M91.20M156.86M200.68M261.85M411.11M761.88M974.78M723.89M401.59M332.27M405.05M-644.90M191.51M7.01M-185.92M-178.51M
EBITDA Margin16.08%21.34%25.06%25.78%24.04%25.90%30.00%43.39%36.03%25.60%17.06%12.11%17.00%-28.85%10.24%0.39%-16.31%-15.31%
Net Income10.84M22.75M66.46M117.81M151.91M192.93M288.29M604.58M795.35M522.46M216.58M158.76M192.31M-791.20M45.94M-195.32M-373.37M-379.82M
Net Income Margin8.60%14.41%18.26%19.36%18.20%19.09%21.04%34.43%29.39%18.48%9.20%5.78%8.07%-35.40%2.46%-10.95%-32.76%-32.58%
R&D749.92K4.07M9.48M28.02M37.85M36.07M64.73M65.69M90.94M78.90M56.47M55.12M48.07M49.02M48.15M22.56M31.40M45.07M
R&D as % of Total Revenue0.59%2.58%2.61%4.61%4.53%3.57%4.72%3.74%3.36%2.79%2.40%2.01%2.02%2.19%2.57%1.27%2.76%3.87%
Interest Expense1.51M2.05M2.70M4.24M1.69M114.18K5.10M15.65M3.04M6.70M2.39M5.10M17.05M10.47M7.23M6.66M10.70M8.36M
Interest Expense % of Total Revenue1.20%1.30%0.74%0.70%0.20%0.01%0.37%0.89%0.11%0.24%0.10%0.19%0.72%0.47%0.39%0.37%0.94%0.72%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets122.38M185.73M295.77M1.13B1.24B1.45B2.22B4.80B5.43B5.72B6.05B6.14B6.55B5.43B5.86B5.48B5.20B4.86B
Total Liabilities59.37M75.72M119.15M65.90M73.32M113.01M542.64M544.10M419.97M308.37M409.39M350.72M753.22M558.28M804.57M669.05M797.54M886.97M
Total Equity61.02M108.76M175.23M1.06B1.16B1.33B1.62B4.18B4.95B5.37B5.60B5.76B5.77B4.85B5.05B4.84B4.45B4.03B
Cash15.61M33.99M30.21M769.35M582.58M501.98M350.61M2.02B992.05M1.41B1.46B1.32B882.82M761.56M764.67M744.35M698.54M897.40M
Total Debt25.00M38.00M60.00M---359.61M194.81M5.74M-22.80M-463.00M252.04M403.33M343.06M505.57M-
Net Debt9.39M4.01M29.79M-769.35M-582.58M-501.98M9.01M-1.83B-986.31M-1.41B-1.43B-1.32B-419.82M-509.53M-361.34M-401.29M-192.96M-

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow209.80K10.18M42.47M75.73M84.02M174.22M175.38M518.96M486.50M687.21M123.89M445.82M178.53M92.68M281.02M148.42M166.69M257.68M
Investing Cash Flow-12.64M-27.52M-65.55M-40.18M-218.16M-230.84M-611.38M-649.49M-1.29B-152.48M-80.53M-496.86M-945.63M-33.18M-258.58M-117.73M-322.15M-
Financing Cash Flow18.88M35.71M19.30M703.59M-52.63M-23.98M284.62M1.71B-243.60M-41.47M-45.10M-23.16M341.66M-335.25M-9.37M-166.01M141.14M-
Capital Expenditure12.62M19.63M65.05M43.87M231.28M203.98M527.42M570.53M1.15B258.92M96.72M364.21M605.89M349.33M173.49M238.19M195.60M163.98M
Free Cash Flow-12.41M-9.45M-22.58M31.87M-147.26M-29.75M-352.04M-51.58M-659.25M428.30M27.17M81.60M-427.36M-256.65M107.53M-89.77M-28.91M93.70M
Dividends Paid1.27M2.07M2.70M3.06M55.63M23.98M29.49M70.74M105.82M44.15M45.10M20.63M20.43M103.13M4.73M70.10M8.42M11.09M
FCF to OCF-5914.84%-92.84%-53.16%42.08%-175.27%-17.08%-200.73%-9.94%-135.51%62.32%21.93%18.30%-239.38%-276.91%38.26%-60.48%-17.34%36.36%
Dividend Paid to FCF-10.19%-21.86%-11.96%9.61%-37.78%-80.59%-8.38%-137.14%-16.05%10.31%165.99%25.28%-4.78%-40.18%4.40%-78.09%-29.11%11.84%

Earnings

Report DateSep 30, 2011Feb 29, 2012Apr 25, 2012Aug 14, 2012Oct 25, 2012Feb 27, 2013Apr 24, 2013Aug 28, 2013Oct 27, 2013Jan 27, 2014Apr 25, 2014Jul 30, 2014Oct 26, 2014Mar 2, 2015Apr 26, 2015Aug 11, 2015Oct 19, 2015Mar 16, 2016Apr 5, 2016Aug 26, 2016Oct 28, 2016Mar 1, 2017Apr 20, 2017Aug 29, 2017Oct 27, 2017Apr 27, 2018Aug 29, 2018Oct 29, 2018Apr 24, 2019Aug 27, 2019Oct 29, 2019Apr 25, 2020Aug 28, 2020Oct 13, 2020Apr 29, 2021Aug 27, 2021Oct 14, 2021Apr 28, 2022Aug 30, 2022Oct 27, 2022Apr 27, 2023Aug 28, 2023Oct 23, 2023May 17, 2024Aug 29, 2024Oct 25, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--0.030.030.03-0.04-0.040.020.030.040.040.040.050.100.020.080.060.110.100.110.060.14----------------------------
EPS Actual0.010.020.030.020.020.020.020.030.030.040.030.040.030.050.050.110.080.100.090.180.100.170.150.100.060.050.060.04-0.040.020.02-0.000.020.060.010.020.03-0.460.000.000.000.01-0.01-0.110.00-0.020.010.000.00-0.200.010.02
Surprise--0.00%-33.33%-33.33%--50.00%--25.00%100.00%0.00%0.00%-25.00%25.00%0.00%10.00%300.00%25.00%50.00%63.64%0.00%54.55%150.00%-28.57%----------------------------
Timing--After-hoursAfter-hoursAfter-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours------Pre-market-----After-hours--After-hours-----

Key Statistics & Ratios

Market Cap6.72B
Enterprise Value6.66B
Trailing P/E0.00
Forward P/E27.86
PEG Ratio0.00
Price / Sales6.40
Price / Book1.70
EPS-0.18
Book Value1.95
Revenue (TTM)1.05B
Gross Profit (TTM)250.67M
EBITDA128.29M
Profit Margin-35.47%
Operating Margin8.95%
Return on Equity-9.42%
Return on Assets-0.42%
Shares Outstanding2.06B
Shares Float1.02B
Beta0.47
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.03Jun 9, 2023
20211×
0.05Jun 9, 2021
20201×
0.01Jul 8, 2020
20191×
0.01Jul 18, 2019
20181×
0.02Jul 12, 2018
20171×
0.02Jun 15, 2017
20161×
0.05May 10, 2016
20151×
0.03Apr 8, 2015
20141×
0.01Mar 5, 2014
20131×
0.01May 31, 2013
20121×
0.03Apr 17, 2012

Stock Splits

  • May 10, 201620:10
  • Apr 8, 201520:10
  • Mar 5, 201419:10
  • Apr 17, 201213:10